Transcriptome analysis of distinct mouse strains reveals kinesin light chain-1 splicing as an amyloid-B accumulation modifier

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 7, 2014, Pages 2638-2643

  Morihara, Takashi ^a   Hayashi, Noriyuki ^a   Yokokoji, Mikiko ^a   Akatsu, Hiroyasu ^b   Silverman, Michael A ^a,c   Kimura, Nobuyuki ^d   Sato, Masahiro ^a   Saito, Yuhki ^e   Suzuki, Toshiharu ^e   Yanagida, Kanta ^a   Kodama, Takashi S ^a   Tanaka, Toshihisa ^a   Okochi, Masayasu ^a   Tagami, Shinji ^a   Kazui, Hiroaki ^a   Kudo, Takashi ^a   Hashimoto, Ryota ^a,f   Itoh, Naohiro ^a   Nishitomi, Kouhei ^a   Yamaguchi Kabata, Yumi ^g   Tsunoda, Tatsuhiko ^h   Takamura, Hironori ^a   Katayama, Taiichi ^a   Kimura, Ryo ⁱ   Kamino, Kouzin ^a,j   Hashizume, Yoshio ^b   Takeda, Masatoshi ^a   more..

^a OSAKA UNIVERSITY   (Japan)

^b Fukushimura Hospital   (Japan)

^c SIMON FRASER UNIVERSITY   (Canada)

^d NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^e HOKKAIDO UNIVERSITY   (Japan)

^f HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g TOHOKU UNIVERSITY   (Japan)

^h Institute of Physical and Chemical Research   (Japan)

ⁱ KYOTO UNIVERSITY   (Japan)

^j Yamato Mental Medical Center   (Japan)

more..

Author keywords

Alternative splicing; Mouse to human translation

Indexed keywords

AMYLOID BETA PROTEIN; KINESIN; KINESIN LIGHT CHAIN 1; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; TRANSCRIPTOMICS;

ALTERNATIVE SPLICING; MOUSE-TO-HUMAN TRANSLATION;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN; CROSSES, GENETIC; GENE EXPRESSION PROFILING; HUMANS; MICE; MICROTUBULE-ASSOCIATED PROTEINS; PROTEIN ISOFORMS; SPECIES SPECIFICITY;

EID: 84894350553     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1307345111     Document Type: Article

References (45)

1. Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE (2007) Systematic metaanalyses of Alzheimer disease genetic association studies: The AlzGene database. Nat Genet 39(1):17-23.
2. Naj AC, et al. (2011) Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet 43(5):436-441.
3. Hollingworth P, et al. (2011) Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet 43(5):429-435.
4. Seshadri S, et al. (2010) Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 303(18):1832-1840.
5. Harold D, et al. (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 41(10):1088-1093.
6. Lambert J-C, et al. (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 41(10):1094-1099.
7. Jonsson T, et al. (2013) Variant of TREM2 associated with the risk of Alzheimer's disease. N Engl J Med 368(2):107-116.
8. Guerreiro R, et al. (2013) TREM2 variants in Alzheimer's disease. N Engl J Med 368(2): 117-127.
9. Gatz M, et al. (2006) Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry 63(2):168-174.
10. Holton P, et al. (2013) Initial assessment of the pathogenic mechanisms of the recently identified Alzheimer risk Loci. Ann Hum Genet 77(2):85-105.
11. Bertram L, Tanzi RE (2009) Genome-wide association studies in Alzheimer's disease. Hum Mol Genet 18(R2):R137-R145.
12. Antonarakis SE, Chakravarti A, Cohen JC, Hardy J (2010) Mendelian disorders and multifactorial traits: The big divide or one for all? Nat Rev Genet 11(5):380-384.
13. Pedersen NL (2010) Reaching the limits of genome-wide significance in Alzheimer disease: Back to the environment. JAMA 303(18):1864-1865.
14. Flint J, Eskin E (2012) Genome-wide association studies in mice. Nat Rev Genet 13(11): 807-817.
15. Flint J, Valdar W, Shifman S, Mott R (2005) Strategies for mapping and cloning quantitative trait genes in rodents. Nat Rev Genet 6(4):271-286.
16. Womack JE, Jang H-J, Lee MO (2012) Genomics of complex traits. Ann N Y Acad Sci 1271:33-36.
17. Bras J, Guerreiro R, Hardy J (2012) Use of next-generation sequencing and other wholegenome strategies to dissect neurological disease. Nat Rev Neurosci 13(7):453-464.
18. Ryman D, Gao Y, Lamb BT (2008) Genetic loci modulating amyloid-beta levels in a mouse model of Alzheimer's disease. Neurobiol Aging 29(8):1190-1198.
19. Sebastiani G, et al. (2006) Mapping genetic modulators of amyloid plaque deposition in TgCRND8 transgenic mice. Hum Mol Genet 15(15):2313-2323.
20. Sullivan PF, Fan C, Perou CM (2006) Evaluating the comparability of gene expression in blood and brain. Am J Med Genet B Neuropsychiatr Genet 141B(3):261-268.
21. Lehman EJH, et al. (2003) Genetic background regulates beta-amyloid precursor protein processing and beta-amyloid deposition in the mouse. Hum Mol Genet 12(22):2949-2956.
22. Grubb SC, Maddatu TP, Bult CJ, Bogue MA (2009) Mouse phenome database. Nucleic Acids Res 37(Database Issue):D720-D730.
23. Petkov PM, et al. (2004) An efficient SNP system for mouse genome scanning and elucidating strain relationships. Genome Res 14(9):1806-1811.
24. McCart AE, Mahony D, Rothnagel JA (2003) Alternatively spliced products of the human kinesin light chain 1 (KNS2) gene. Traffic 4(8):576-580.
25. Webster JA, et al. (2009) Genetic control of human brain transcript expression in Alzheimer disease. Am J Hum Genet 84(4):445-458.
26. Sutherland GT, Janitz M, Kril JJ (2011) Understanding the pathogenesis of Alzheimer's disease: Will RNA-Seq realize the promise of transcriptomics? J Neurochem116(6):937-946.
27. Lee Y, et al. (2012) Variants affecting exon skipping contribute to complex traits. PLoS Genet 8(10):e1002998.
28. Emilsson V, et al. (2008) Genetics of gene expression and its effect on disease. Nature 452(7186):423-428.
29. Chen Y, et al. (2008) Variations in DNA elucidate molecular networks that cause disease. Nature 452(7186):429-435.
30. Hirokawa N (1998) Kinesin and dynein superfamily proteins and the mechanism of organelle transport. Science 279(5350):519-526.
31. Rahman A, Kamal A, Roberts EA, Goldstein LSB (1999) Defective kinesin heavy chain behavior in mouse kinesin light chain mutants. J Cell Biol 146(6):1277-1288.
32. Wozniak MJ, Allan VJ (2006) Cargo selection by specific kinesin light chain 1 isoforms. EMBO J 25(23):5457-5468.
33. Stokin GB, et al. (2005) Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 307(5713):1282-1288.
34. Killian RL, Flippin JD, Herrera CM, Almenar-Queralt A, Goldstein LSB (2012) Kinesin light chain 1 suppression impairs human embryonic stem cell neural differentiation and amyloid precursor protein metabolism. PLoS One 7(1):e29755.
35. Kamal A, Stokin GB, Yang Z, Xia CH, Goldstein LS (2000) Axonal transport of amyloid precursor protein is mediated by direct binding to the kinesin light chain subunit of kinesin-I. Neuron 28(2):449-459.
36. Kamal A, Almenar-Queralt A, LeBlanc JF, Roberts EA, Goldstein LS (2001) Kinesinmediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP. Nature 414(6864):643-648.
37. Lazarov O, et al. (2005) Axonal transport, amyloid precursor protein, kinesin-1, and the processing apparatus: Revisited. J Neurosci 25(9):2386-2395.
38. Araki Y, et al. (2007) The novel cargo Alcadein induces vesicle association of kinesin-1 motor components and activates axonal transport. EMBO J 26(6):1475-1486.
39. Vagnoni A, et al. (2012) Calsyntenin-1 mediates axonal transport of the amyloid precursor protein and regulates Aß production. Hum Mol Genet 21(13):2845-2854.
40. Goldstein LSB (2012) Axonal transport and neurodegenerative disease: Can we see the elephant? Prog Neurobiol 99(3):186-190.
41. Muresan V, Muresan Z (2012) A persistent stress response to impeded axonal transport leads to accumulation of amyloid-ß in the endoplasmic reticulum, and is a probable cause of sporadic Alzheimer's disease. Neurodegener Dis 10(1-4):60-63.
42. Bettens K, Sleegers K, Van Broeckhoven C (2013) Genetic insights in Alzheimer's disease. Lancet Neurol 12(1):92-104.
43. Lim GP, et al. (2005) A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J Neurosci 25(12):3032-3040.
44. Kimura R, et al. (2007) The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between beta-amyloid production and tau phosphorylation in Alzheimer disease. Hum Mol Genet 16(1):15-23.
45. Hayashi N, et al. (2010) KIBRA genetic polymorphism influences episodic memory in Alzheimer's disease, but does not show association with disease in a Japanese cohort. Dement Geriatr Cogn Disord 30(4):302-308.